Vesalius Biocapital Archives

Home Vesalius Biocapital

Latest Posts

News and Trends 29 Jun 2023

Vesalius Biocapital to invest €95M in life science companies

Vesalius Biocapital, a Luxembourg-based life sciences venture capital investor, has announced the first close of its fourth fund, Vesalius Biocapital IV, securing more than €95 million ($103.7 million) of commitments. The fund has attracted investors including the European Investment Fund (EIF). Starting immediately Vesalius Biocapital IV is to invest in first and best-in-class European life […]

June 29, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 25 Jun 2019

Update: Fund for Late-Stage European Biotechs Closes Final Round With €120M

Update (25/06/2019): The Luxembourg-based investor Vesalius Biocapital III has completed the final closing of a €120M fund to boost late-stage life science companies. Around 10-15 companies will receive investments from the fund, including specialists in drug development, med-tech, and diagnostics. Three companies have become beneficiaries so far, including the Finnish women’s health drug company Forendo […]

June 25, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Portugal Ventures Ricardo Perdigao Henriques

Interview 29 Nov 2017

What’s Going on in the Biotech Ecosystem of Portugal?

The biotech ecosystem in Portugal is rapidly growing. Ricardo Perdigao, Investment Manager at Portugal Ventures, discusses the country’s potential in this field. Portugal has seen the number of life sciences startups triple between 2008 to 2015. A study by Portugal Ventures links this growth to a better funding environment and to researchers being more aware that […]

November 29, 2017 - 3 minutesmins - By External Contributor

biotech portugal vesalius biocapital fund

News and Trends 20 Sep 2017

Biotech in Portugal gets a Boost with New Investment Fund

Vesalius Biocapital and the Portuguese National Promotional Bank have announced a new joint venture that will invest in late-stage healthcare companies. The Instituição Financeira de Desenvolvimento (IFD), or Portuguese National Promotional Bank, is launching its first joint investment with an international VC, Vesalius Biocapital. Though its size hasn’t been revealed yet, the new fund is a 50/50 venture […]

September 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

prostate cancer trod encage leuven ucl vesalius

News and Trends 11 Jan 2016

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

TROD Medical, the medical device company developing tools for focal ablation, today announced that it has received CE Mark Approval for its Encage device. Encage is a breakthrough in treatment for prostate cancer, one of the most common soft tissue cancers in the world with around 240,000 new cases every year in the US alone. […]

January 11, 2016 - 2 minutesmins - By Dani Bancroft

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vesalius Biocapital

Vesalius Biocapital to invest €95M in life science companies

Update: Fund for Late-Stage European Biotechs Closes Final Round With €120M

What’s Going on in the Biotech Ecosystem of Portugal?

Biotech in Portugal gets a Boost with New Investment Fund

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!